Roivant Sciences Ltd. (ROIV) is expected to report earnings on Monday, November 9, 2026, after the close. Estimated release time 07:14 ET. Consensus EPS estimate is $-0.41.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-06 | FY2026 Q2 | $-0.30 | $-0.33 | -10.1% | $1.44M |
| 2026-05-20 | FY2026 Q1 | $-0.29 | $-0.28 | +3.5% | $2.52M |
| 2026-02-06 | FY2025 Q4 | $-0.30 | $-0.24 | +19.9% | $2.00M |
| 2025-11-10 | FY2025 Q3 | $-0.32 | $-0.20 | +36.9% | $1.57M |
| 2025-02-10 | FY2024 Q4 | $-0.25 | $-0.13 | +48.6% | $9.02M |
| 2024-08-08 | FY2024 Q2 | $-0.24 | $0.12 | +149.3% | $55.13M |
| 2024-05-30 | FY2024 Q1 | $-0.26 | $-0.23 | +13.0% | $28.93M |
| 2024-02-13 | FY2023 Q4 | $-0.31 | $-0.21 | +32.0% | $37.14M |
ROIV has beaten consensus EPS in 7 of its last 8 reported quarters.
See ROIV on the live calendar →